Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : A.I.M Users Group Bulletin Board -- Ignore unavailable to you. Want to Upgrade?

To: LemonHead who wrote (13145)	10/12/2000 11:57:18 AM
From: Bernie Goldberg	Respond to of 18928

No not really. All I can tell you is that BGEN bet earnings estimates for the third quarter, which I am sure you are aware of. It is one of a very few profitable biotech companies. I had sales on MRK in April, May, and July which brought my cash reserve up to 18%. Since July it has just bounced around just short of my next sales target (80 3/8). I've gotten used to it doing this however. It gives a flurry of AIM activity for anywheres from 2 to 3 months and then settles down and does nothing except pay dividends for a while. Right now I'm getting over $1,000 a year in dividends. Not bad for a $5,000 investment over 5 yrs ago. That of course is not counting the 6% from my cash reserve. I think you need some stocks like MRK when you are sitting in a rockin' chair. Lets you sleep a little better at night. Bernie